Tryp Therapeutics Inc
The TRYPF stock trades on Otc Markets
Company Description
Tryp Therapeutics is leading psychedelic drug development beyond mental health. Tryp Therapeutics focuses on areas of unmet medical need where other treatments have fallen short. Our pharmaceutical focus on psilocybin has the potential to transform the treatment of chronic pain and other indications, and relieve the suffering of millions of patients. Addressing unmet needs with proven potential. Tryp Therapeutics is one of the first players to help realize this promise, leading the next wave of psychedelic drug development that extends beyond mental health.
Drug Pipeline
Source: Tryp Therapeutics Inc - 20220924
Asset
Indication
Pre-Clinical
Ph1
Ph2
Ph3
Reg/Com
Phase
TRP-8802
Neuropsychiatric Disorders
Phase 2
TRP-8803
Neuropsychiatric Disorders
Phase 2
0 Comments on TRYPF stock
Newest
Conversation